Evoke Pharma Inc.

NASDAQ: EVOK · Real-Time Price · USD
5.08
-0.06 (-1.17%)
At close: Aug 15, 2025, 3:59 PM
5.00
-1.48%
After-hours: Aug 15, 2025, 07:53 PM EDT

Evoke Pharma Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-1.57 -0.45 -1.03 -1.96
PEG Ratio
0.02 0.04 0.05 0.04
PS Ratio
0.82 0.68 3.36 10.94
PB Ratio
0.00 -1.36 2.06 4.98
P/FCF Ratio
-1.54 -0.7 -1.28 -1.43
P/OCF Ratio
-1.54 -0.7 -1.28 -1.43
OCF/S Ratio
-0.53 -0.96 -2.63 -7.63
Debt / Equity Ratio
0.00 -1.94 1.26 1.41
Quick Ratio
1.62 0.66 6.91 7.38
Current Ratio
1.66 0.71 7.08 7.51
Asset Turnover
0.59 0.73 0.21 0.15
Interest Coverage
-10.38 -14.86 -15.57 -16.3
Return on Equity
n/a 3.02 -2 -2.54
Return on Assets
-0.31 -1.1 -0.69 -0.85
Return on Invested Capital
-0.43 -3.07 -0.74 -0.94
Dividend Yield
n/a n/a n/a n/a
Payout Ratio
n/a n/a n/a n/a
Gross Profit Margin
0.97 0.96 0.85 0.80
Net Profit Margin
-0.52 -1.5 -3.25 -5.58
Pretax Profit Margin
-0.52 -1.5 -3.28 -5.28
Operating Profit Margin
-0.51 -1.43 -3.1 -5.04
FCF Margin
n/a n/a n/a n/a
EBITDA Margin
-0.47 -1.41 -3.08 -4.97